KOLs and Biopharma: Building Value Through Collaboration

Session details:

This session explores the evolving partnership between Key Opinion Leaders (KOLs) and the biopharmaceutical industry, highlighting how meaningful engagement goes beyond transactional interactions. By fostering collaboration rooted in scientific exchange, professional trust, and shared purpose, biopharma and KOLs can jointly advance innovation while keeping the ultimate focus on improved patient outcomes.